What sector does Relmada Therapeutics, Inc (RLMD) operate in?
Relmada Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Relmada Therapeutics, Inc (RLMD) current stock price?
As of the latest data, Relmada Therapeutics, Inc stock price is $6.47, with a previous close of $6.51. Relmada Therapeutics, Inc lost -$0.04 in the last trading session, representing a -0.61% loss.
What is Relmada Therapeutics, Inc (RLMD) current market capitalization?
Relmada Therapeutics, Inc market cap is approximately 679.27 million.
What is Relmada Therapeutics, Inc (RLMD) Earnings Per Share (EPS)?
The trailing EPS is -$1.09, and the forward EPS is -$0.41.
What is Relmada Therapeutics, Inc (RLMD) EBITDA?
Relmada Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.05 million.
Does Relmada Therapeutics, Inc (RLMD) pay dividends?
No. Relmada Therapeutics, Inc does not pay a dividend.
When is Relmada Therapeutics, Inc (RLMD) next earnings report?
Relmada Therapeutics, Inc is expected to release its next earnings report on June 30, 2026.
What is Relmada Therapeutics, Inc (RLMD) beta (volatility) score?
Relmada Therapeutics, Inc has a beta of 0.833, meaning its volatility is roughly in line with the market.